University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia

dc.contributor.authorGonzalez, Maria Camila
dc.contributor.authorTovar-Rios, Diego Alejandro
dc.contributor.authorAlves, Guido
dc.contributor.authorDalen, Ingvild
dc.contributor.authorWilliams-Gray, Caroline H.
dc.contributor.authorCamacho, Marta
dc.contributor.authorForsgren, Lars
dc.contributor.authorBäckström, David
dc.contributor.authorLawson, Rachael A.
dc.contributor.authorMacleod, Angus D.
dc.contributor.authorCounsell, Carl E.
dc.contributor.authorPaquet, Claire
dc.contributor.authorDeLena, Carlo
dc.contributor.authorD'Antonio, Fabrizia
dc.contributor.authorPilotto, Andrea
dc.contributor.authorPadovani, Alessandro
dc.contributor.authorBlanc, Frédéric
dc.contributor.authorFalup-Pecurariu, Cristian
dc.contributor.authorLewis, Simon J.G.
dc.contributor.authorRejdak, Konrad
dc.contributor.authorPapuc, Ewa
dc.contributor.authorHort, Jakub
dc.contributor.authorNedelska, Zuzana
dc.contributor.authorO'Brien, John
dc.contributor.authorBonanni, Laura
dc.contributor.authorMarquié, Marta
dc.contributor.authorBoada, Mercè
dc.contributor.authorPytel, Vanesa
dc.contributor.authorAbdelnour, Carla
dc.contributor.authorAlcolea, Daniel
dc.contributor.authorBeyer, Katrin
dc.contributor.authorTysnes, Ole Bjørn
dc.contributor.authorAarsland, Dag
dc.contributor.authorMaple-Grødem, Jodi
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.date.accessioned2023-10-20T10:31:01Z
dc.date.available2023-10-20T10:31:01Z
dc.date.issued2023-06-15
dc.descriptionFunding Information: The University of Stavanger supported M.C.G. The CamPaIGN study has received funding from the Wellcome Trust, the Medical Research Council, the Patrick Berthoud Trust, and the NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014). The ICICLE‐PD study was funded by Parkinson's UK (J‐0802, G‐1301, G‐1507) and supported by the Lockhart Parkinson's Disease Research Fund, National Institute for Health Research (NIHR) Newcastle Biomedical Research Unit and Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The PICNICS study was funded by the Cure Parkinson's Trust, the Van Geest Foundation, the Medical Research Council, Parkinson's UK, and the NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014). The NYPUM study was supported by grants from the Swedish Medical Research Council, Erling‐Persson Foundation, the Swedish Brain Foundation (Hjärnfonden), Umeå University, Västerbotten County Council, King Gustaf V and Queen Victoria Freemason Foundation, Swedish Parkinson Foundation, Swedish Parkinson Research Foundation, Kempe Foundation, Swedish PD Association, the European Research Council, and the Knut and Alice Wallenberg Foundation. The PINE study was funded by Parkinson's UK (grant numbers G0502, G0914, and G1302), the Scottish Chief Scientist Office (CAF/12/05, PCL/17/10), Academy of Medical Sciences, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and SPRING. The PARKWEST study was supported by the Research Council of Norway (grant# 177966), the Western Norway Regional Health Authority (grant# 911218 and # 911949), Reberg legacy and the Norwegian Parkinson's Research Foundation. The PICC collaboration has been supported by The Chief Scientist Office of the Scottish Government (PCL/17/10), the Academy of Medical Sciences, Parkinson's UK (initial collaborator meeting) and the Norwegian Association for Public Health. The DEMVEST Study was supported by the regional health authorities of Western Norway, Helse‐Vest (grant# 911973). Motol University Hospital's Czech Brain Aging Study was supported by the National Institute for Neurological Research (Programme EXCELES, ID Project No. LX22NPO5107)—Funded by the European Union—Next Generation EU and by Charles University grant PRIMUS 22/MED/011. The Sant Pau Initiative on Neurodegeration (SPIN) cohort was supported by the Fondo de Investigaciones Sanitario (FIS), Instituto de Salud Carlos III (PI14/01126, PI17/01019 and PI20/01473 to JF, PI13/01532 and PI16/01825 to RB, PI18/00335 to MCI, PI18/00435 and INT19/00016 to DA, PI17/01896 and AC19/00103to AL) and the CIBERNED program (Program 1, Alzheimer Disease to AL), jointly funded by Fondo Europeo de Desarrollo Regional, Unión Europea, “Una manera de hacer Europa”. It was also supported by the National Institutes of Health (NIA grants 1R01AG056850‐01A1; R21AG056974; and R01AG061566), by Generalitat de Catalunya (2017‐SGR‐547, SLT006/17/125, SLT006/17/119, SLT002/16/408) and “Marató TV3” foundation grants 20141210, 044412 and 20142610. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The sponsors were not involved in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication. The authors declare that there are no conflicts of interest relevant to this work. Funding Sources and Conflicts of Interest:en
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent446693
dc.identifier250167759
dc.identifieree12e08f-2feb-4238-9b80-dffde1503ccb
dc.identifier85158093631
dc.identifier37332651
dc.identifier.citationGonzalez, M C, Tovar-Rios, D A, Alves, G, Dalen, I, Williams-Gray, C H, Camacho, M, Forsgren, L, Bäckström, D, Lawson, R A, Macleod, A D, Counsell, C E, Paquet, C, DeLena, C, D'Antonio, F, Pilotto, A, Padovani, A, Blanc, F, Falup-Pecurariu, C, Lewis, S J G, Rejdak, K, Papuc, E, Hort, J, Nedelska, Z, O'Brien, J, Bonanni, L, Marquié, M, Boada, M, Pytel, V, Abdelnour, C, Alcolea, D, Beyer, K, Tysnes, O B, Aarsland, D & Maple-Grødem, J 2023, 'Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia', Movement Disorders Clinical Practice, vol. 10, no. 6, pp. 980-986. https://doi.org/10.1002/mdc3.13752en
dc.identifier.doi10.1002/mdc3.13752
dc.identifier.issn2330-1619
dc.identifier.otherORCID: /0000-0001-6622-7839/work/164505599
dc.identifier.otherORCID: /0000-0002-6284-4239/work/191926822
dc.identifier.urihttps://hdl.handle.net/2164/21969
dc.identifier.urlhttps://www.scopus.com/pages/publications/85158093631en
dc.language.isoeng
dc.relation.ispartofMovement Disorders Clinical Practiceen
dc.subjectdementia with Lewy bodiesen
dc.subjectinternational cohorten
dc.subjectParkinson's disease dementiaen
dc.subjectparkinsonismen
dc.subjectrate of cognitive declineen
dc.subjectR Medicineen
dc.subjectNeurologyen
dc.subjectClinical Neurologyen
dc.subjectWellcome Trusten
dc.subjectBRC‐1215‐20014en
dc.subjectMedical Research Council (MRC)en
dc.subjectBRC‐1215‐20014en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectBRC‐1215‐20014en
dc.subjectScottish Funding Councilen
dc.subjectCAF/12/05, PCL/17/10en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleCognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementiaen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Gonzalez_etal_MD_Cognitive_and_Motor_VOR.pdf
Size:
436.22 KB
Format:
Adobe Portable Document Format

Collections